home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

43 rows where docket_id = "FDA-2007-D-0369" and posted_year = 2020 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: last_modified, posted_date (date)

document_type 3

  • Supporting & Related Material 34
  • Notice 7
  • Other 2

posted_year 1

  • 2020 · 43 ✖

agency_id 1

  • FDA 43
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2007-D-0369-0529 FDA None FDA-2007-D-0369 PSG_203858 - Draft Guidance on Lomitapide Mesylate Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:16Z   0 0 0900006484968cb1
FDA-2007-D-0369-0522 FDA None FDA-2007-D-0369 PSG_022563 - Draft Guidance on Calcipotriene Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:14Z   0 0 0900006484968caa
FDA-2007-D-0369-0526 FDA None FDA-2007-D-0369 PSG_200063 - Draft Guidance on Bupropion Hydrochloride; Naltrexone Hydrochloride Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:15Z   0 0 0900006484968cae
FDA-2007-D-0369-0513 FDA None FDA-2007-D-0369 PSG_011751 - Draft Guidance on Fluphenazine Hydrochloride Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:11Z   0 0 0900006484968d7b
FDA-2007-D-0369-0525 FDA None FDA-2007-D-0369 PSG_061904 - Draft Guidance on Erythromycin Ethylsuccinate Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:15Z   0 0 0900006484968cad
FDA-2007-D-0369-0533 FDA None FDA-2007-D-0369 PSG_207071 - Draft Guidance on Azelaic Acid Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:17Z   0 0 0900006484968cb5
FDA-2007-D-0369-0537 FDA None FDA-2007-D-0369 PSG_208910 - Draft Guidance on Vancomycin Hydrochloride Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:17Z   0 0 0900006484968cb9
FDA-2007-D-0369-0540 FDA None FDA-2007-D-0369 PSG_211635 - Draft Guidance on Diazepam Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:18Z   0 0 0900006484968cbc
FDA-2007-D-0369-0514 FDA None FDA-2007-D-0369 PSG_016418 - Draft Guidance on Propranolol Hydrochloride Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:13Z   0 0 0900006484968d7c
FDA-2007-D-0369-0544 FDA None FDA-2007-D-0369 PSG_212862 - Draft Guidance on Pretomanid Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:20Z   0 0 0900006484968cc0
FDA-2007-D-0369-0523 FDA None FDA-2007-D-0369 PSG_050207 - Draft Guidance on Erythromycin Ethylsuccinate Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:15Z   0 0 0900006484968cab
FDA-2007-D-0369-0531 FDA None FDA-2007-D-0369 PSG_205777 - Draft Guidance on Naloxone Hydrochloride; Oxycodone Hydrochloride Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:17Z   0 0 0900006484968cb3
FDA-2007-D-0369-0534 FDA None FDA-2007-D-0369 PSG_207318 - Draft Guidance on Pimavanserin Tartrate Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:17Z   0 0 0900006484968cb6
FDA-2007-D-0369-0543 FDA None FDA-2007-D-0369 PSG_212161 - Draft Guidance on Tafamidis Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:18Z   0 0 0900006484968cbf
FDA-2007-D-0369-0521 FDA None FDA-2007-D-0369 PSG_022013 - Draft Guidance on Clobetasol Propionate Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:14Z   0 0 0900006484968ca9
FDA-2007-D-0369-0517 FDA None FDA-2007-D-0369 PSG_018662 - Draft Guidance on Isotretinoin Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:14Z   0 0 0900006484968ca5
FDA-2007-D-0369-0541 FDA None FDA-2007-D-0369 PSG_211672 - Draft Guidance on Lefamulin Acetate Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:18Z   0 0 0900006484968cbd
FDA-2007-D-0369-0530 FDA None FDA-2007-D-0369 PSG_205613 - Draft Guidance on Budesonide Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:16Z   0 0 0900006484968cb2
FDA-2007-D-0369-0518 FDA None FDA-2007-D-0369 PSG_021438 - Draft Guidance on Propranolol Hydrochloride Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:14Z   0 0 0900006484968ca6
FDA-2007-D-0369-0520 FDA None FDA-2007-D-0369 PSG_021978 - Draft Guidance on Desonide Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:14Z   0 0 0900006484968ca8
FDA-2007-D-0369-0510 FDA None FDA-2007-D-0369 Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability Notice Notice of Availability 2020-11-19T05:00:00Z 2020 11 2020-11-19T05:00:00Z 2021-01-20T04:59:59Z 2020-11-19T14:06:28Z 2020-25602 0 0 09000064849686e1
FDA-2007-D-0369-0519 FDA None FDA-2007-D-0369 PSG_021951 - Draft Guidance on Isotretinoin Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:14Z   0 0 0900006484968ca7
FDA-2007-D-0369-0539 FDA None FDA-2007-D-0369 PSG_211225 - Draft Guidance on Ceritinib Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:18Z   0 0 0900006484968cbb
FDA-2007-D-0369-0538 FDA None FDA-2007-D-0369 PSG_210833 - Draft Guidance on Clobazam Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:18Z   0 0 0900006484968cba
FDA-2007-D-0369-0511 FDA None FDA-2007-D-0369 PSG_008720 - Draft Guidance on Levorphanol Tartrate Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:11Z   0 0 0900006484968d79
FDA-2007-D-0369-0524 FDA None FDA-2007-D-0369 PSG_050529 - Draft Guidance on Erythromycin Ethylsuccinate; Sulfisoxazole Acetyl Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:15Z   0 0 0900006484968cac
FDA-2007-D-0369-0535 FDA None FDA-2007-D-0369 PSG_207960 - Draft Guidance on Methylphenidate Hydrochloride Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:17Z   0 0 0900006484968cb7
FDA-2007-D-0369-0542 FDA None FDA-2007-D-0369 PSG_211996 - Draft Guidance on Tafamidis Meglumine Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:18Z   0 0 0900006484968cbe
FDA-2007-D-0369-0516 FDA None FDA-2007-D-0369 PSG_018553 - Draft Guidance on Propranolol Hydrochloride Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:13Z   0 0 0900006484968d7e
FDA-2007-D-0369-0527 FDA None FDA-2007-D-0369 PSG_200655 - Draft Guidance on Fluorodopa F-18 Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:15Z   0 0 0900006484968caf
FDA-2007-D-0369-0512 FDA None FDA-2007-D-0369 PSG_010571 - Draft Guidance on Prochlorperazine Maleate Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:11Z   0 0 0900006484968d7a
FDA-2007-D-0369-0528 FDA None FDA-2007-D-0369 PSG_202292 - Draft Guidance on Crofelemer Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:15Z   0 0 0900006484968cb0
FDA-2007-D-0369-0532 FDA None FDA-2007-D-0369 PSG_205920 - Draft Guidance on Epinephrine Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:17Z   0 0 0900006484968cb4
FDA-2007-D-0369-0536 FDA None FDA-2007-D-0369 PSG_208246 - Draft Guidance on Tofacitinib Citrate Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:17Z   0 0 0900006484968cb8
FDA-2007-D-0369-0515 FDA None FDA-2007-D-0369 PSG_017351 - Draft Guidance on Hydrocortisone Acetate Supporting & Related Material Guidance 2020-11-19T05:00:00Z 2020 11     2024-11-06T23:41:13Z   0 0 0900006484968d7d
FDA-2007-D-0369-0508 FDA None FDA-2007-D-0369 Product-Specific Guidance for Tiotropium Bromide; Draft Guidance for Industry; Availability Notice Notice of Availability 2020-11-18T05:00:00Z 2020 11 2020-11-18T05:00:00Z 2021-01-20T04:59:59Z 2021-01-16T02:01:08Z 2020-25412 0 0 09000064849661a3
FDA-2007-D-0369-0509 FDA None FDA-2007-D-0369 Draft Guidance on Tiotropium Bromide Other Guidance 2020-11-18T05:00:00Z 2020 11 2020-11-18T05:00:00Z   2024-11-06T23:40:25Z   1 0 0900006484965ca1
FDA-2007-D-0369-0502 FDA None FDA-2007-D-0369 Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability Notice Notice of Availability 2020-08-31T04:00:00Z 2020 8 2020-08-31T04:00:00Z 2020-10-31T03:59:59Z 2020-10-24T01:00:52Z 2020-19164 0 0 090000648482cf4b
FDA-2007-D-0369-0498 FDA None FDA-2007-D-0369 Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability Notice Notice of Availability 2020-06-04T04:00:00Z 2020 6 2020-06-04T04:00:00Z 2020-08-04T03:59:59Z 2020-08-04T01:01:45Z 2020-12100 0 0 09000064846c9e54
FDA-2007-D-0369-0493 FDA None FDA-2007-D-0369 Product-Specific Guidances; Guidance for Industry; Availability Notice Notice of Availability 2020-04-14T04:00:00Z 2020 4 2020-04-14T04:00:00Z   2024-11-06T23:33:20Z 2020-07751 1 0 09000064844a2653
FDA-2007-D-0369-0484 FDA None FDA-2007-D-0369 Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability Notice Notice of Availability 2020-03-03T05:00:00Z 2020 3 2020-03-03T05:00:00Z 2020-05-05T03:59:59Z 2020-04-24T01:01:24Z 2020-04320 0 0 09000064843d883c
FDA-2007-D-0369-0482 FDA None FDA-2007-D-0369 Draft Guidance on Levonorgestrel Other Guidance 2020-01-23T05:00:00Z 2020 1 2020-01-23T05:00:00Z 2020-03-24T03:59:59Z 2024-11-12T23:15:48Z   1 0 09000064842dfec7
FDA-2007-D-0369-0481 FDA None FDA-2007-D-0369 Product-Specific Guidance for Levonorgestrel; Intrauterine Device; Revised Draft Guidance for Industry; Availability Notice Notice of Availability 2020-01-23T05:00:00Z 2020 1 2020-01-23T05:00:00Z 2020-03-24T03:59:59Z 2020-04-09T17:01:46Z 2020-01072 0 0 09000064842de6de

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;
Powered by Datasette · Queries took 3844.145ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API